{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:00:53Z","timestamp":1788440453412,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/dad.0b013e3181a23f3b","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T03:13:54Z","timestamp":1253157234000},"page":"619-625","source":"Crossref","is-referenced-by-count":11,"title":["Melanoma Hyperpigmentation Is Strongly Associated With KIT Alterations"],"prefix":"10.1097","volume":"31","author":[{"given":"Julie M","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Antonescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210202","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to imatinib mesylate in KIT-mutated melanoma.","volume":"26","author":"Hodi","year":"2008","journal-title":"J Clin Oncol"},{"key":"R2-1-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-007-0524-2","article-title":"C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma.","volume":"452","author":"Rivera","year":"2008","journal-title":"Virchows Arch"},{"key":"R3-1-20210202","first-page":"939","article-title":"Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.","volume":"10","author":"Montone","year":"1997","journal-title":"Mod Pathol"},{"key":"R4-1-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-3163-2-8","article-title":"Immunohistochemical determination of HER-2\/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications.","volume":"2","author":"Potti","year":"2003","journal-title":"J Carcinog"},{"key":"R5-1-20210202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmg.2003.016667","article-title":"Absence of BRAF mutations in UV-protected mucosal melanomas.","volume":"41","author":"Edwards","year":"2004","journal-title":"J Med Genet"},{"key":"R6-1-20210202","first-page":"6997","article-title":"BRAF and RAS mutations in human lung cancer and melanoma.","volume":"62","author":"Brose","year":"2002","journal-title":"Cancer Res"},{"key":"R7-1-20210202","first-page":"756","article-title":"Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.","volume":"63","author":"Satyamoorthy","year":"2003","journal-title":"Cancer Res"},{"key":"R8-1-20210202","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0050120","article-title":"Improving melanoma classification by integrating genetic and morphologic features.","volume":"5","author":"Viros","year":"2008","journal-title":"PLoS Med"},{"key":"R9-1-20210202","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1167\/iovs.03-1196","article-title":"c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?","volume":"45","author":"All-Ericsson","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-1-20210202","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/annonc\/mdg192","article-title":"Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117).","volume":"14","author":"Fiorentini","year":"2003","journal-title":"Ann Oncol"},{"key":"R11-1-20210202","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/cncr.11812","article-title":"Imatinib mesylate causes hypopigmentation in the skin.","volume":"98","author":"Tsao","year":"2003","journal-title":"Cancer"},{"key":"R12-1-20210202","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00008390-200508000-00004","article-title":"KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.","volume":"15","author":"Janku","year":"2005","journal-title":"Melanoma Res"},{"key":"R13-1-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.22681","article-title":"L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.","volume":"121","author":"Antonescu","year":"2007","journal-title":"Int J Cancer"},{"key":"R14-1-20210202","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.bjc.6604482","article-title":"Phase II trial of imatinib mesylate in patients with metastatic melanoma.","volume":"99","author":"Kim","year":"2008","journal-title":"Br J Cancer"},{"key":"R15-1-20210202","first-page":"3329","article-title":"Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.","volume":"9","author":"Antonescu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R16-1-20210202","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejca.2003.11.025","article-title":"Use of c-KIT\/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group.","volume":"40","author":"Debiec-Rychter","year":"2004","journal-title":"Eur J Cancer"},{"key":"R17-1-20210202","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"R18-1-20210202","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/modpathol.3880210","article-title":"Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).","volume":"13","author":"Miettinen","year":"2000","journal-title":"Mod Pathol"},{"key":"R19-1-20210202","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma.","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"R20-1-20210202","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/01.pas.0000141391.91677.a4","article-title":"Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors.","volume":"28","author":"Busam","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R21-1-20210202","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression.","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R22-1-20210202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9440(10)64946-2","article-title":"KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.","volume":"156","author":"Lux","year":"2000","journal-title":"Am J Pathol"},{"key":"R23-1-20210202","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer.","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"R24-1-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1309\/R8N1CN04KKFV6M7T","article-title":"Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.","volume":"122","author":"Guerriere-Kovach","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R25-1-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.2910520207","article-title":"Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor.","volume":"52","author":"Natali","year":"1992","journal-title":"Int J Cancer"},{"key":"R26-1-20210202","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1034\/j.1600-0560.2003.00090.x","article-title":"Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array.","volume":"30","author":"Shen","year":"2003","journal-title":"J Cutan Pathol"},{"key":"R27-1-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/106689690401200206","article-title":"Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.","volume":"12","author":"Stefanou","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"R28-1-20210202","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.jid.5700632","article-title":"Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma.","volume":"127","author":"Liu","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R29-1-20210202","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas.","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R30-1-20210202","first-page":"3883","article-title":"BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.","volume":"63","author":"Dong","year":"2003","journal-title":"Cancer Res"},{"key":"R31-1-20210202","first-page":"3955","article-title":"Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.","volume":"63","author":"Gorden","year":"2003","journal-title":"Cancer Res"},{"key":"R32-1-20210202","first-page":"3362","article-title":"BRAF mutations in metastatic melanoma: a possible association with clinical outcome.","volume":"9","author":"Kumar","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R33-1-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi.","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet"},{"key":"R34-1-20210202","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1158\/0008-5472.CAN-08-0235","article-title":"Identification of a novel subgroup of melanomas with KIT\/cyclin-dependent kinase-4 overexpression.","volume":"68","author":"Smalley","year":"2008","journal-title":"Cancer Res"},{"key":"R35-1-20210202","first-page":"137","article-title":"The kit-ligand (steel factor) and its receptor c-kit\/W: pleiotropic roles in gametogenesis and melanogenesis.","volume":"125-","author":"Besmer","year":"1993","journal-title":"Dev Suppl"},{"key":"R36-1-20210202","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/sj.jid.5700125","article-title":"Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes.","volume":"126","author":"Alexeev","year":"2006","journal-title":"J Invest Dermatol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000372-200910000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:00:33Z","timestamp":1618020033000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-200910000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3181a23f3b","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2255956.1872054","asserted-by":"object"}]},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}